Reducing hospital admissions for COPD patients using home nursing interventions
The Effect of Post-Discharge Multiple Nursing Interventions on the Number of Hospital Admissions, Dyspnea Level, and Quality of Life in COPD Patients Receiving Home Oxygen Therapy: A Randomized Controlled Study
This study tests if home nursing support and education can help people with severe COPD stay healthier and avoid going back to the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 74 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Necmettin Erbakan University Academic / other |
| Locations | 1 site (Konya) |
| Trial ID | NCT05730088 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients with stage 4 chronic obstructive pulmonary disease (COPD) and aims to reduce hospital admissions through multiple nursing interventions conducted via phone calls and health education. Participants will receive follow-up calls shortly after hospital discharge to address their health concerns and monitor their condition. The intervention includes the use of a mobile application for communication and support, ensuring patients have access to necessary information about their illness and treatment. The goal is to improve the quality of life for COPD patients and decrease the frequency of acute exacerbations that lead to hospitalization.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with stage 4 COPD who have access to a mobile device and the internet.
Not a fit: Patients with earlier stages of COPD or those with additional lung diseases or communication barriers may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for COPD patients and reduce the burden of hospital admissions.
How similar studies have performed: Other studies have shown promise in using telehealth and nursing interventions to manage chronic diseases, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with stage 4 (group D) COPD according to GOLD criteria * Being 18 years or older, * Having a video computer, tablet or phone, * Having an internet connection at home or on the phone, * Residing in the city centre of Konya, * Not having a communication problem, such as an inability to understand/speak Turkish, that would prevent participation in the research, * Being literate, * Using an oxygen concentrator at home. Exclusion Criteria: * Being illiterate, * Being diagnosed with first, second and third-stage COPD according to GOLD criteria, * Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.), * Having physical and/or mental disabilities, * Being visually impaired and/or hearing impaired, * Having a communication problem that prevents participation in the research, such as an inability to understand/speak Turkish, * Having been diagnosed with Covid-19 or having had it in the past, * Having a psychiatric disease
Where this trial is running
Konya
- Selçuk Tıp Fakültesi Hastanesi — Konya, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Di̇lek Ci̇ngi̇l — https://erbakan.edu.tr/hemsirelikfak
- Study coordinator: Hasan Bakir
- Email: smhasanbakir@gmail.com
- Phone: 05055346870
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.